Nir Naor
EVP, CFO & Treasurer at Neuronetics, Inc. (STIM) since July 2026
Nir Naor has filed 9 insider reports with the SEC since June 2023, as EVP and CFO & Treasurer at Neuronetics, Inc. (STIM), director at Brainstorm Cell Therapeutics Inc. (BCLI) and CFO at Axogen, Inc. (AXGN). The latest filing, on July 23, 2026, reports grant or award at Neuronetics, Inc. (STIM).
- Filings
- 9
- Companies
- 3
- Bought on market
- None
- Sold on market
- None
Companies where Nir Naor is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| EVP, CFO & Treasurersince July 2026 | 500,000 | $1.25 | Jul 23, 2026 | ||||
| Directorsince June 2023 | 31,465 | May 20, 2026 | |||||
| CFOsince December 2023 | 260,868 | $55.75 | Jan 6, 2025 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jul 23, 2026STIMEVP, CFO & Treasurer Naor Nir was granted 500,000 sharesForm 4Grant or award
- Jul 23, 2026STIMNir Naor became an insiderForm 3New insider
- Feb 26, 2026BCLISEC Form 4 filed by Director Naor NirForm 4Grant or award
- Jan 6, 2025AXGNCFO Naor Nir covered exercise/tax liability with 39,132 shares, decreasing direct ownership by 13% to 260,868 unitsForm 4Shares withheld for taxes or exercise price
- Jan 1, 2025BCLIDirector Naor Nir was granted 30,666 shares, increasing direct ownership by 3,838% to 31,465 unitsForm 4Grant or award
- Jan 1, 2024AXGNNaor Nir was granted 300,000 sharesForm 4Grant or award
- Dec 4, 2023AXGNNir Naor became an insiderForm 3New insider
- Jun 19, 2023BCLISEC Form 4 filed by Naor NirForm 4Grant or award
Compare Nir Naor with
- Nir Naor vs Glenn P Muir1 shared
- Nir Naor vs Robert Cascella1 shared
- Nir Naor vs Sasha Cucuz1 shared
- Nir Naor vs Jorey Chernett1 shared
- Nir Naor vs Joseph A. Tyndall1 shared
- Nir Naor vs Marc A Began1 shared
Other insiders at the same companies
- Glenn P MuirSTIM
- Robert CascellaSTIM
- Sasha CucuzSTIM
- Jorey ChernettSTIM
- Joseph A. TyndallAXGN
- Marc A BeganAXGN
- Amy McBride WendellAXGN
- Kathy Johnson WeilerAXGN
- Jacob A FrenkelBCLI
- Peter Joe PittsBCLI
- Cory AndersonSTIM
- Burke William P. Mr.AXGN
- John JohnsonAXGN
- Paul ThomasAXGN
- Alan M LevineAXGN
- Avinash AminSTIM
Questions about Nir Naor
- What is Nir Naor's role at Neuronetics, Inc.?
- Nir Naor reports to the SEC as EVP and CFO & Treasurer at Neuronetics, Inc. (STIM), according to the latest filing on July 23, 2026. Nir Naor has also filed as director at Brainstorm Cell Therapeutics Inc. (BCLI) and CFO at Axogen, Inc. (AXGN).
- How many shares does Nir Naor own?
- After the latest filing that states it, Nir Naor directly owned 500,000 shares of Neuronetics, Inc. (STIM), 31,465 shares of Brainstorm Cell Therapeutics Inc. (BCLI) and 260,868 shares of Axogen, Inc. (AXGN). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Nir Naor bought or sold stock recently?
- No open-market purchases or sales by Nir Naor are on file. The filings report grant or award and shares withheld for taxes or exercise price.
- How do I get alerts when Nir Naor files?
- Follow Nir Naor on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Nir Naor (SEC CIK 0001982278). Totals count each trade once, skipping amendments whose original is on file, from Jun 21, 2023 on. View on SEC EDGAR · Get this as JSON